No evidence of benefical effect of GB virus type C infection on the course of hiv infection [2]

AIDS

Volumn 16, Issue 10, 2002, Pages 1430-1431

  Quiros Roldan, Eugenia ^a,b   Maroto, M Carmen ^a   Torti, Carlo ^b   Moretti, Francesca ^b   Casari, Salvatore ^b   Pan, Angelo ^b   Carosi, Giampiero ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; COMORBIDITY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEPATITIS G; HEPATITIS G VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; EPIDEMIOLOGY; ISOLATION AND PURIFICATION; MORTALITY; RETROSPECTIVE STUDY; VIROLOGY; VIRUS HEPATITIS; VIRUS INFECTION;

CONFOUNDING FACTORS (EPIDEMIOLOGY); DISEASE PROGRESSION; FEMALE; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMAN; MALE; RETROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; HUMANS;

EID: 0037024765     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200207050-00019     Document Type: Letter

References (6)

1. GBV-C RNA presence in several high-risk groups
2. GB virus C in patients with liver disease of unknown aetiology
3. Effect of coinfection with GB virus C on survival among patients with HIV infection
4. Infection with GB-C and reduced mortality among HIV-infected patients
5. GBV-RNA detection by PCR with several primer pairs
6. Fighting virus with virus?. GBV and HIV coinfections